tga bpc 157 approval status Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled Retatrutide in Australia. These toxic effects may be linked to a contaminant in the bpc-157 tga approval BPC-157 and
Description
"Essendon has finalised drug ban compensation claims with all current players"
All compounds we stock have been independently third-party tested to 99%+ purity we dont rely on manufacturer certificates alone
Contact us to learn more or schedule a consultation
But the moment it wears off, the sneezing returns
This injection is for subcutaneous use only and should be taken as directed by your healthcare provider.
